Glycomine Announces First Pediatric Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG
SAN CARLOS, Calif.--(BUSINESS WIRE)--Dec 11, 2023--
Source: eagletribune.com
Steven Axon News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Steven Axon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Steven Axon Today - Breaking & Trending Today
Glycomine Announces First Pediatric Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential T
Promising data in adult patients supports advancement into pediatric patientsData from this portion of the clinical program will inform pivotal studySAN CARLOS, Calif.--(BUSINESS WIRE)--#CDG--Glycomine, Inc., a clinical-stage biotechnology company focused on developing new therapies for orphan diseases, announced th...
Source: pharmiweb.com